{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T19:36:22Z","timestamp":1783452982270,"version":"3.55.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medical Genetics"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/j.ejmg.2013.05.007","type":"journal-article","created":{"date-parts":[[2013,6,7]],"date-time":"2013-06-07T02:47:17Z","timestamp":1370573237000},"page":"416-419","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["CNR1 variation is associated with the age at onset in Huntington disease"],"prefix":"10.1016","volume":"56","author":[{"given":"Eugen","family":"Kloster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carsten","family":"Saft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f6rg T.","family":"Epplen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larissa","family":"Arning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmg.2013.05.007_bib1","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A\u00a0novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.ejmg.2013.05.007_bib2","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s13311-012-0112-2","article-title":"Huntington's disease and the striatal medium spiny neuron: cell-autonomous and non-cell-autonomous mechanisms of disease","volume":"9","author":"Ehrlich","year":"2012","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ejmg.2013.05.007_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-5-40","article-title":"Huntington's disease: a clinical review","volume":"5","author":"Roos","year":"2010","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.ejmg.2013.05.007_bib4","doi-asserted-by":"crossref","first-page":"3498","DOI":"10.1073\/pnas.0308679101","article-title":"Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset","volume":"101","author":"Wexler","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.ejmg.2013.05.007_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2217\/fnl.11.65","article-title":"Genetic modifiers of Huntington\u2019s disease: beyond CAG","volume":"7","author":"Arning","year":"2012","journal-title":"Future Neurol."},{"key":"10.1016\/j.ejmg.2013.05.007_bib6","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.2174\/138161208785740108","article-title":"The endocannabinoid system in Huntington's disease","volume":"14","author":"Pazos","year":"2008","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.ejmg.2013.05.007_bib7","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/S0306-4522(00)00008-7","article-title":"The pattern of neurodegeneration in Huntington's disease: a comparative study of cannabinoid, dopamine, adenosine and GABA(A) receptor alterations in the human basal ganglia in Huntington's disease","volume":"97","author":"Glass","year":"2000","journal-title":"Neuroscience"},{"key":"10.1016\/j.ejmg.2013.05.007_bib8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.pneurobio.2006.11.006","article-title":"The endocannabinoid pathway in Huntington's disease: a comparison with other neurodegenerative diseases","volume":"81","author":"Maccarrone","year":"2007","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.ejmg.2013.05.007_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/brain\/awq278","article-title":"Loss of striatal type 1 cannabinoid receptors is a key pathogenic factor in Huntington's disease","volume":"134","author":"Blazquez","year":"2011","journal-title":"Brain"},{"key":"10.1016\/j.ejmg.2013.05.007_bib10","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng1219","article-title":"Huntingtin interacts with REST\/NRSF to modulate the transcription of NRSE-controlled neuronal genes","volume":"35","author":"Zuccato","year":"2003","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmg.2013.05.007_bib11","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1326-6-32","article-title":"PGC-1alpha downstream transcription factors NRF-1 and TFAM are genetic modifiers of Huntington disease","volume":"6","author":"Taherzadeh-Fard","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.ejmg.2013.05.007_bib12","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1212\/WNL.0b013e318249f683","article-title":"CAG repeat expansion in Huntington disease determines age at onset in a fully dominant fashion","volume":"78","author":"Lee","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.ejmg.2013.05.007_bib13","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.neulet.2011.04.003","article-title":"Association between a cannabinoid receptor gene (CNR1) polymorphism and cannabinoid-induced alterations of the auditory event-related P300 potential","volume":"496","author":"Stadelmann","year":"2011","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejmg.2013.05.007_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","article-title":"Haploview: analysis and visualization of LD and haplotype maps","volume":"21","author":"Barrett","year":"2005","journal-title":"Bioinformatics"},{"key":"10.1016\/j.ejmg.2013.05.007_bib15","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1038\/ng2135","article-title":"The role of site accessibility in microRNA target recognition","volume":"39","author":"Kertesz","year":"2007","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ejmg.2013.05.007_bib16","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1002\/humu.21641","article-title":"Genome-wide identification of SNPs in microRNA genes and the SNP effects on microRNA target binding and biogenesis","volume":"33","author":"Gong","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.ejmg.2013.05.007_bib17","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/13556210020040271","article-title":"The cannabinoid receptor gene (CNR1) is not affected in German i.v. drug users","volume":"6","author":"Heller","year":"2001","journal-title":"Addict Biol."},{"key":"10.1016\/j.ejmg.2013.05.007_bib18","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1476-5381.2011.01365.x","article-title":"Prospects for cannabinoid therapies in basal ganglia disorders","volume":"163","author":"Fernandez-Ruiz","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.ejmg.2013.05.007_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/phar.1187","article-title":"The pharmacologic and clinical effects of medical cannabis","volume":"33","author":"Borgelt","year":"2013","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ejmg.2013.05.007_bib20","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.2967\/jnumed.110.077156","article-title":"Widespread decrease of type 1 cannabinoid receptor availability in Huntington disease in\u00a0vivo","volume":"51","author":"Van Laere","year":"2010","journal-title":"J.\u00a0Nucl. Med."},{"key":"10.1016\/j.ejmg.2013.05.007_bib21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.nbd.2011.03.006","article-title":"Worsening of Huntington disease phenotype in CB1 receptor knockout mice","volume":"42","author":"Mievis","year":"2011","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.ejmg.2013.05.007_bib22","first-page":"9","article-title":"The implication of CNR1 gene's polymorphisms in the modulation of endocannabinoid system effects","volume":"47","author":"Dinu","year":"2009","journal-title":"Rom. J. Intern. Med."},{"key":"10.1016\/j.ejmg.2013.05.007_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1369-1600.2009.00198.x","article-title":"CNR1 gene polymorphisms in addictive disorders: a systematic review and a meta-analysis","volume":"16","author":"Benyamina","year":"2011","journal-title":"Addict Biol."},{"key":"10.1016\/j.ejmg.2013.05.007_bib24","doi-asserted-by":"crossref","first-page":"3461","DOI":"10.1093\/hmg\/dds177","article-title":"A\u00a0greatly extended PPARGC1A genomic locus encodes several new brain-specific isoforms and influences Huntington disease age of onset","volume":"21","author":"Soyal","year":"2012","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.ejmg.2013.05.007_bib25","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4161\/cc.7.7.5666","article-title":"MiRSNPs or MiR-polymorphisms, new players in microRNA mediated regulation of the cell: Introducing microRNA pharmacogenomics","volume":"7","author":"Mishra","year":"2008","journal-title":"Cell Cycle"},{"key":"10.1016\/j.ejmg.2013.05.007_bib26","doi-asserted-by":"crossref","first-page":"e54791","DOI":"10.1371\/journal.pone.0054791","article-title":"Genetic variations creating MicroRNA target sites in the FXN 3'-UTR affect frataxin expression in Friedreich ataxia","volume":"8","author":"Bandiera","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmg.2013.05.007_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.euroneuro.2012.12.002","article-title":"Polymorphisms in microRNA target sites influence susceptibility to schizophrenia by altering the binding of miRNAs to their targets","author":"Gong","year":"2013","journal-title":"Eur. Neuropsychopharmacol."},{"key":"10.1016\/j.ejmg.2013.05.007_bib28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/mp.2008.15","article-title":"A\u00a0common polymorphism in serotonin receptor 1B mRNA moderates regulation by miR-96 and associates with aggressive human behaviors","volume":"14","author":"Jensen","year":"2009","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.ejmg.2013.05.007_bib29","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ajhg.2007.09.021","article-title":"Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein","volume":"82","author":"Wang","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ejmg.2013.05.007_bib30","doi-asserted-by":"crossref","first-page":"4535","DOI":"10.1093\/nar\/gkm480","article-title":"Aberrant allele frequencies of the SNPs located in microRNA target sites are potentially associated with human cancers","volume":"35","author":"Yu","year":"2007","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.ejmg.2013.05.007_bib31","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s00439-012-1205-z","article-title":"Population stratification may bias analysis of PGC-1alpha as a modifier of age at Huntington disease motor onset","volume":"131","author":"Ramos","year":"2012","journal-title":"Hum. Genet."},{"key":"10.1016\/j.ejmg.2013.05.007_bib32","unstructured":"PITA: http:\/\/genie.weizmann.ac.il\/pubs\/mir07\/mir07_prediction.html, miRNASNP: http:\/\/www.bioguo.org\/miRNASNP\/geneTargets.php."}],"container-title":["European Journal of Medical Genetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721213001250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1769721213001250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T03:40:45Z","timestamp":1761709245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1769721213001250"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013,8]]}},"alternative-id":["S1769721213001250"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmg.2013.05.007","relation":{},"ISSN":["1769-7212"],"issn-type":[{"value":"1769-7212","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CNR1 variation is associated with the age at onset in Huntington disease","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medical Genetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmg.2013.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}